Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
VRCA
$4.57
-4.69%
VRCA
· Verrica Pharmaceuticals Inc.
$4.57
-0.23 (-4.69%)
At close · Oct 1
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current business plan and current capital resources, combined with the uncertainty regarding the availability of additional funding, we have concluded that there is substantial doubt regarding our ability to continue as a going concern within one year after the date these consolidated financial statements are issued.”View the 10-Q filed Aug 6, 2026
Market Cap
$75.07M
Shares
17.18M
Volume · Oct 1
55.31K
Avg daily vol (3M)
62.01K
All webcasts
Earnings call · FY2025 Q4
Verrica Pharmaceuticals Inc. (VRCA) Q4 2025 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue · derived Q4
$5.09M
+1380.2% YoY
Net income · derived Q4
-$8.07M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 11, 2026 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 11, 2026 · complete as-filed document